全球大佬财富轨迹追踪
Serenity(白毛股神)
Serenity (@aleabitoreddit)Serenity(白毛股神)@aleabitoreddit发帖2026-07-06

Kelper将XFAB上调至“买入”,理由是其主要客户Melexis需求强劲,AI驱动的SiC/GaN/光子学增长,以及估值相对于同行较低。

Kelper将XFAB上调至“买入”,理由是其主要客户Melexis需求强劲,AI驱动的SiC/GaN/光子学增长,以及估值相对于同行较低。

Kelper upgrades $XFAB to "Buy" citing: - Melexis demand strengthening “week-after-week, day-after-day” (their lead customer). - AI giving XFAB a structural growth leg with SiC, GaN, and photonics offsetting auto cyclicality. - Scarce Western speciality foundries like $SILEX commanding higher multiples. "X-Fab remains the cheapest specialty foundry peer on every multiple, trading at 4.8x 2027 EV/EBITDA versus a peer median of 14.5x" I treat this as good signal for the core fundamentals improving like auto players. But in terms of unpriced long term growth vectors, I'm personally looking at XFAB from a different angle in terms of photonics growth with photonixfab. Given $NVDA as a potential key driver. But it's hard for traditional firms to price these types of active developments into valuation models until there's volume contracts.
原帖X / @aleabitoreddit

关联股票

NVDA看多
+0.37% 今日
+9.80% 90天

被引用为XFAB通过photonixfab实现光子学增长的潜在关键驱动力,是未定价的长期增长向量。

去交易
XFAB看多

Kelper基于强劲的基本面证据将评级上调至买入:Melexis需求持续增强,AI在SiC/GaN/光子学领域提供结构性增长,且股价仅为2027年EV/EBITDA的4.8倍,而同行中位数为14.5倍。

去交易
SILEX看多

被提及为稀缺的西方特种晶圆代工同行,强化了特种晶圆代工主题。

去交易
仅供参考 · 风向标是信息工具,不构成投资建议,不推荐买卖任何证券。行程可能基于官方确认前的媒体报道。公开战绩存在幸存者偏差。投资决策与责任由您自行承担。